Skip to Main Content

Paper Details

Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser.
Br J Ophthalmol
16
2021
Patients, VEGF, anti-VEGF, anti-vascular endothelial growth factor, branch retinal vein occlusion, cataract, dexamethasone, macular oedema, patients, vascular endothelial growth factor
Aged, Angiogenesis Inhibitors, Dexamethasone, Drug Therapy, Combination, Female, Follow-Up Studies, Glucocorticoids, Humans, Intravitreal Injections, Laser Therapy, Macula Lutea, Macular Edema, Male, Retinal Vein Occlusion, Retrospective Studies, Treatment Outcome, Vascular Endothelial Growth Factors, Visual Acuity
Author NameAffiliation
Richard Gale
Richard GaleYork Teaching Hospital NHS Foundation Trust
Maria PikoulaInstitute of Health Informatics, University College London
Aaron LeeUniversity of Washington
Spiros DenaxasInstitute of Health Informatics, University College London
Catherine EganMoorfields Eye Hospital NHS Foundation Trust
Adnan TufailMoorfields Eye Hospital NHS Foundation Trust
Paul TaylorInstitute of Health Informatics, University College London
  • 1 - 8

Datasets

Release 1.2